KELLI CLAIR: Open Payments
NPI 1902107295 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 113 payments from 15 companies in 2025. Trend: 2023 $3,358 · 2024 $2,146 · 2025 $2,126
Food & beverage: $2,036Education: $90
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $446 |
| Janssen Biotech, Inc. | 17 | $361 |
| UCB, Inc. | 18 | $292 |
| GENZYME CORPORATION | 5 | $185 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| ABBVIE INC. | 11 | $135 |
| Incyte Corporation | 4 | $110 |
| Organon LLC | 8 | $81 |
| Galderma Laboratories, L.P. | 4 | $76 |
| Arcutis Biotherapeutics, Inc. | 3 | $66 |
Products named: TREMFYA, COSENTYX, Bimzelx, DUPIXENT, SKYRIZI, OPZELURA, Rhapsido, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
